Is BPA Bad?

نسخه فارسی

English Version

[DISCLAIMER: I don’t have any expertise in these matters, this is just a summary of my very limited search and my understanding of the matter based on that search. The reason I got interested in this topic is that my mom asked whether this is true or not, and shall she be worried. Here is my take.]

Summary

BPA (Bisphenol A) and BPS (Bisphenol S) are chemicals in plastics, can linings, and thermal receipt paper. They are endocrine disruptors: they can mimic estrogen and interfere with the body’s hormonal systems. The short answer to “is BPA bad?” is: probably somewhat, but the science is more uncertain than most headlines suggest, and what’s worth doing about it depends on who you are.

What the evidence clearly supports: - BPA and BPS are present in nearly everyone’s body and have real biological activity: they bind to hormone receptors - Animal and cell studies show a range of health effects - Fetal and infant exposure is the most legitimate concern - Dietary exposure (canned food, food-contact plastics) matters more than receipts for most people - Occupational exposure for cashiers handling hundreds of receipts daily is a genuine concern - Reducing unnecessary plastic use is a reasonable precaution

Where the science is genuinely uncertain: - Whether current human exposure levels actually cause disease: most evidence comes from animal studies or observational data, not controlled human trials - “BPA-free” labeling is largely illusory: BPS has similar hormone-disrupting properties, just different and incompletely understood kinetics - The EU and US regulatory limits differ by 12,000×, not because one has better data, but because they apply different philosophies to the same uncertain evidence

The honest bottom line: These chemicals are probably not harmless, particularly for developing organisms. But the more alarming framing in public health advocacy, that touching a receipt is dangerous or that BPA alone explains waves of chronic disease, outpaces what the human evidence actually supports. Reduce dietary plastic exposure where you reasonably can, don’t panic about occasional receipts, and apply more caution if pregnant.

What are BPA and BPS?

Bisphenol A (BPA) has been used since the 1950s to make: - Hard polycarbonate plastics (water bottles, food containers) - Epoxy resin linings in metal cans - Thermal receipt paper - Medical devices, dental sealants, CDs, eyeglass lenses

Bisphenol S (BPS) emerged as a “safer” replacement for BPA when concerns were raised, but is structurally similar and found in: - “BPA-free” thermal receipt paper - Some plastic products marketed as BPA-free - Food contact materials

Why the Concern?

These chemicals are endocrine disruptors, i.e. they can mimic hormones (particularly estrogen) and potentially interfere with: - Reproductive development - Metabolic function - Neurological development - Immune system function

The Scale of Exposure:

• Approximately 93% of Americans have detectable BPA in their bodies
• Global production: Over 6 billion pounds of BPA annually
• BPA is found in nearly universal human biomonitoring studies
• Cashiers and retail workers show elevated levels

Current Regulatory Status

European Union (Strict Approach): - In 2023, the European Food Safety Authority (EFSA) lowered the tolerable daily intake by 20,000-fold to a new limit of 0.2 nanograms per kilogram of body weight per day - In 2024, the EU banned BPA in all food contact packaging - BPS is also included in restrictions

United States (Permissive Approach): - FDA maintains the 1980s-era standard: 50 micrograms per kilogram per day. This is approximately 12,000 times more permissive than the EU standard - BPA banned in baby bottles (2012), but based on “market abandonment” not safety determination - The FDA states “BPA is safe at current levels occurring in foods”

The Gap:

The divergence between EU and US regulatory positions reflects fundamentally different approaches to uncertain science: the EU emphasizes precaution when evidence is unclear, while the US requires stronger proof of harm before restricting chemicals.

Scientific Evidence: What We Know

1. Widespread Presence and Exposure

Established facts: - BPA detected in 93% of US population (CDC biomonitoring) - Multiple exposure routes: diet, dermal contact, dust inhalation - Cashiers have approximately 2–3 times higher urinary BPA levels than general population - Receipt paper contains 250–1,000 times more BPA than a can of food

2. Thermal Receipt Paper as an Exposure Source

Confirmed findings: - Approximately 80% of US receipts contain BPA or BPS - In thermal paper, BPA/BPS are in “free form” (not chemically bound) - This allows easy transfer to skin and other surfaces - Studies confirm dermal absorption occurs from receipt handling

3. Dermal Absorption Mechanisms

What studies show: - BPA is absorbed through skin: 25% absorption rate in 24 hours - BPS has lower absorption: 0.4% in 24 hours (60x slower than BPA) - Hand sanitizer/lotion dramatically increases absorption (up to 185x) - BPA from skin contact remains in body longer than ingested BPA (days vs. hours) - Only 2.2% of dermally applied BPA becomes systemically available

4. Transfer to Other Objects

Documented: - BPA/BPS transfers from receipts to paper currency, cards, and other items in wallets - Secondary exposure from contaminated objects is measurable - Studies have found BPA contamination on paper money

5. Biological Activity

Uncontested: - BPA and BPS bind to estrogen receptors - They show estrogenic activity in laboratory assays - Both can interact with other hormone receptors (thyroid, androgen) - The binding affinity is weak: thousands of times weaker than natural estrogen

Scientific Evidence: What Remains Uncertain

1. Human Health Effects at Real-World Exposure Levels

The evidence problem: - Most health effects are demonstrated in animal studies or cell cultures - Studies use doses often higher than typical human exposure - Human epidemiological studies show associations but cannot prove causation - Confounding factors (diet, lifestyle, socioeconomic status) are difficult to separate

Claimed effects with uncertain human evidence: - Obesity and metabolic syndrome - Type 2 diabetes - Reproductive dysfunction and infertility - Certain cancers (breast, prostate) - Neurodevelopmental disorders (ADHD, learning disabilities) - Cardiovascular disease

The fundamental challenge: Animal studies suggest these effects, human observational studies show correlations, but establishing causation in humans at real-world doses remains difficult.

2. The Reproducibility Problem

Why this matters:

Reproducibility is fundamental to scientific credibility. If a finding cannot be independently replicated, it may be: - A statistical artifact (false positive) - An artifact of specific experimental conditions - Subject to publication bias (only “positive” results published) - Influenced by researcher expectations or methodology

The BPA situation: - A 2004 Harvard Center for Risk Analysis found “no consistent affirmative evidence for low-dose BPA effects” - Many headline-grabbing BPA studies have never been independently reproduced - Different laboratories using different methods get inconsistent results - This doesn’t prove BPA is safe, but it means we can’t be confident about specific claimed effects

Funding and bias concerns: - Industry-funded studies tend to find BPA safer (about 90% find no effect) - Academic/government studies tend to find harm (about 90% find effects) - This could indicate: - Industry suppression or manipulation - Better study design in industry or academic research (standardized protocols) - Different research questions being asked - Publication bias in academic and/or industry research

The scientific community remains divided on how to interpret this pattern.

3. BPS as a Replacement: Mixed Picture

What we know: - BPS was introduced as “safer” with minimal safety testing - BPS has similar hormone-disrupting properties to BPA - BPS absorbs through skin 60 times slower than BPA - BUT: BPS is metabolized more slowly, so more remains in active form - Net effect on human health: genuinely uncertain

The key question: Is slower absorption but longer persistence better or worse than faster absorption with quicker metabolism? We don’t have a clear answer.

4. Dose-Response Relationship: Non-Monotonic Concerns

Classical toxicology assumption: Higher dose = greater effect

Endocrine disruption reality: May not follow this pattern - Hormones operate at extremely low concentrations - Small doses might have effects that large doses don’t¹ - Timing of exposure may matter more than amount - Traditional toxicology methods may miss these effects

Why this creates uncertainty: - Traditional safety testing assumes monotonic dose-response - If BPA doesn’t follow this pattern, current safety limits may be irrelevant - But non-monotonic effects are harder to study and replicate

5. Actual Individual Risk from Receipts

What’s overstated: - “10 seconds of handling exceeds safe thresholds” - misleading because EFSA thresholds are extremely precautionary - “4 minutes to wash it off” - widely cited but poorly sourced - Receipts presented as major individual risk when dietary exposure is typically larger

What’s real: - Occupational exposure for cashiers handling hundreds of receipts daily - Cumulative effect of receipts plus dietary sources - Hand sanitizer dramatically amplifying absorption

Understanding Scientific Uncertainty

What Does It Mean to Be in a “Grey Area”?

Scientific uncertainty doesn’t mean “we know nothing.” It means we have: - Plausible biological mechanisms - Suggestive but not definitive evidence - Contested interpretations of existing data - Different expert conclusions based on the same evidence

For BPA/BPS, the grey area includes:

1. Mechanistic plausibility: We know these chemicals CAN interact with biological systems
2. Animal evidence: Effects are seen in laboratory animals
3. Observational associations: Higher BPA correlates with certain diseases in humans
4. Causal uncertainty: We can’t definitively say BPA causes these diseases in humans at real-world exposures

How to Reason in Grey Areas:

Option 1: Demand definitive proof before action - Wait for conclusive human evidence - Risk missing genuine harms during delay - Potential population-wide exposure continues

Option 2: Apply precautionary principle - Act on plausible concern even without definitive proof - Risk unnecessary restrictions on useful chemicals - May incur economic costs for uncertain benefits

Option 3: Proportional precaution (most scientifically defensible) - Strongest precaution for most vulnerable (pregnant women, infants) - Moderate reduction strategies for general population - Continued research to resolve uncertainties - Regular reassessment as evidence evolves

The Current Scientific Consensus (such as it is):

Most independent scientists would agree: - BPA/BPS are not inert: they have biological activity - Precautionary reduction of exposure is reasonable - Fetal and infant exposure is most concerning - Adult exposure from occasional receipts is probably minimal risk - Dietary sources are larger concern than receipts for most people - More and better human studies are needed

Most independent scientists would disagree on: - Whether current population exposures cause measurable disease - What the “safe” level actually is - Whether BPS is better, worse, or equivalent to BPA - How much weight to give animal studies vs. human studies

Final Conclusions

Balanced Scientific Assessment:

1. For pregnant women and young children: Precaution is well-justified. Evidence is sufficient to recommend minimizing exposure through all routes (dietary and dermal). The precautionary principle is appropriate here because:
2. Developmental windows are particularly vulnerable
3. Effects may be irreversible

4. Cost of avoidance is relatively low

5. For adults (general population): Risk from occasional receipt handling is likely overstated in public health messaging. Primary concern should be dietary exposure. The evidence supports:

6. Reasonable reduction efforts (prefer fresh over canned, glass over plastic)
7. Not panicking about occasional exposures

8. Recognizing uncertainty remains

9. For occupational workers (cashiers): This is a legitimate occupational health concern requiring workplace protections:

10. Daily handling of hundreds of receipts
11. Cumulative exposure over years
12. Often combined with hand sanitizer use

13. Employer responsibility to provide safer alternatives

14. About BPS: “BPA-free” labeling is misleading: BPS appears to have similar concerns, just different kinetics.

What the Global Disease Burden Estimates Mean:

Claims like “127 million cases of metabolic disease attributable to bisphenols” are: - Model-based projections, not counted cases - Based on assumed causal relationships - Useful for policy prioritization - Not equivalent to proven individual causation

Practical Recommendations

For Everyone:

Priority 1: Reduce Dietary Exposure (Most Important)

• Choose fresh or frozen foods over canned when possible
• Use glass or stainless steel containers instead of plastic
• Never microwave food in plastic containers
• Reduce consumption of packaged and processed foods
• Avoid plastic water bottles (especially in hot cars)
• Look for cans labeled “BPA-free lining” (but recognize they may use BPS)

Priority 2: Manage Receipt Exposure (Moderate Importance)

• Request electronic receipts when offered
• Decline paper receipts when you don’t need them
• If keeping receipts:
• Store them in a separate envelope/pocket (not loose in wallet)
• Fold printed side inward
• Keep away from cash and cards
• Wash hands with soap and water after handling receipts
• Never use hand sanitizer immediately before handling receipts
• Always wash hands before eating after touching receipts
• Don’t give receipts to children to hold or play with

Priority 3: General Plastic Reduction

• Avoid plastics marked with recycling code #7 (polycarbonate)
• Don’t use damaged or scratched plastic containers
• Replace plastic baby bottles with glass or stainless steel
• Use wax paper or glass instead of plastic wrap when possible

For Pregnant Women and Parents of Young Children:

All of the above, plus: - Be more strict about avoiding canned foods for baby food - Use glass baby bottles exclusively - Avoid plastic teething toys (choose silicone, wood, or natural rubber) - Don’t allow children to handle receipts - During pregnancy, minimize unnecessary plastic exposure - Choose BPA/BPS-free products when available (recognizing limitations)

For Cashiers and Retail Workers:

• Request employer switch to phenol-free receipt paper
• Wear gloves if handling many receipts daily
• Minimize contact time with receipts
• Don’t use hand sanitizer immediately before handling receipts
• Wash hands thoroughly before eating or breaks
• Don’t place receipts on hot food containers
• Advocate for electronic receipt systems

What NOT to Worry About:

• Touching a single receipt occasionally: risk is minimal
• Shopping at stores: no need to avoid retail environments
• Incidental contact with plastic: focus on high-exposure sources
• Perfect elimination: not realistic or necessary

Additional Resources

For Further Reading: - European Food Safety Authority (EFSA) BPA assessment: https://www.efsa.europa.eu - US FDA BPA information: https://www.fda.gov/food/food-additives-petitions/bisphenol-bpa - Endocrine Society scientific statements on EDCs

Note: This document represents a synthesis of current scientific literature as of February 2026. Scientific understanding continues to evolve, and recommendations may change as new evidence emerges.